期刊文献+

复方甘草酸苷治疗药物性肝病的疗效观察 被引量:8

Clinical Effects of Stronger Neo - Minophagen C(SNMC) on Drug - induced Liver Disease
原文传递
导出
摘要 目的:观察复方甘草酸苷治疗药物性肝病的疗效。方法:60例药物性肝病患者随机均分为治疗组与对照组。在使用维生素、氨基酸等药物常规治疗的基础上,治疗组将复方甘草酸苷注射液60mL溶于5%葡萄糖注射液250mL中静脉滴注,1次·d-1,疗程4wk;对照组将还原型谷胱甘肽1 200mg溶于5%葡萄糖注射液250mL中静脉滴注,1次·d-1,疗程4wk。结果:治疗组与对照组的总有效率分别为96.7%、93.3%(P<0.05);治疗组有2例出现轻度头痛,对照组有1例出现轻度头晕,均经对症治疗后好转,无需减量或停药。结论:复方甘草酸苷治疗药物性肝病的疗效与还原型谷胱甘肽相当。 OBJECTIVE:To investigate the therapeutic effect of Stronger Neo-Minophagen C(SNMC) on drug-induced liver disease.METHODS: 60 cases of drug induced liver disease were randomly divided into the study group and the control group,30 cases in each.The study group was intravenously injected with SNMC 60mL dissolved in 5% glucose 250mL,once per day.The control group was intravenously injected with reduced glutathione 1 200mg dissolved in 5% Glucose 250mL once per day.The treatment course for both groups was four weeks .RESULTS: The overall efficacy rates of the study group and the control group were 96.7% and 93.3% respectively(P〈0.05) .There were 2 cases of slight headache in the study group and 1 case of slight dizziness in the control group,which were all relieved after application of symptomatic treatment without reducing dosage or discontinuing administration.CONCLUSION: The therapeutic -ffect of SNMC on drug introduced liver disease is equivalent with that of reduced glutathione.SNMC can be used on drug - induced liver disease.
出处 《中国药房》 CAS CSCD 北大核心 2007年第2期130-131,共2页 China Pharmacy
关键词 复方甘草酸苷 药物性肝病 还原型谷胱甘肽 Stronger neo-minophagen C Drug-induced liver disease Reduced glutathione
  • 相关文献

参考文献7

二级参考文献12

  • 1季强 唐法娣.药源性疾病[M].北京:人民卫生出版社,1997.165,391.
  • 2Shiro Iino, Toshiro Tango, Takashi Matsushima, et al.Therapeutic effects of Stronger Neo- Minophagen C at different doses on chronic hepatitis and liver cirrhosis[J].Hepatology Ressearch, 2001, 19:31.
  • 3Kumada H Long- term Treatment of Chronic Hepatitis C with Glycyrrhizin[Stronger Neo- Mimophagen C(SNMC) ].for preventing liver Cirrhosis and hepatocellular carcinoma[J].Oncology, 2002, 69:94.
  • 4Tiziana Rossi, Rita Adriana Fano, Mario Castelli, et al.Correlation between high intake of glycyrrhizin and myolysis of the rapillary muscles:An Experimental in vivo Study[J].Pharmacology & Toxicolgy, 1999, 85:221.
  • 5Kroes BH, Beukelman CJ, Vandenberg AJJ, et al.Inhibition of human complement by β- glycyrrhetinic acid[J].Immunology, 1997, 90:115.
  • 6Mackenze MA The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers[J].J Clin Endocrinol Metab, 1999, 70:1 637.
  • 7中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14019
  • 8宋方闻,李学俊,江元森.复方甘草甜素(SNMC)对肝病理改变观察[J].中国现代医学杂志,2001,11(11):24-25. 被引量:192
  • 9曹阳,唐小平,宋方闻.β体甘草酸与α体甘草酸治疗慢性乙型肝炎临床疗效比较[J].中国现代医学杂志,2002,12(7):91-92. 被引量:49
  • 10汪俊韬,于少军,肖炜.复方甘草甜素(美能)在肝病领域的临床应用[J].中国药房,2002,13(8):500-502. 被引量:147

共引文献163

同被引文献57

引证文献8

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部